Alternatively, in almost 50–70% HCC patients, immunostainings identify overexpression of β-actin in cytoplasm and nucleus especially for tumor cell proliferation and suppression of physiological differentiation; however, under nonmalignant situation, high accumulation of β-actin shows less contribution to HCC formation (148). The gene discussed is ACTB; the disease is hepatocellular carcinoma.